Beam Therapeutics Inc (BEAM)
24.79
+1.21
(+5.13%)
USD |
NASDAQ |
Nov 22, 12:56
Beam Therapeutics Shareholders Equity (Quarterly): 791.32M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 791.32M |
| June 30, 2024 | 854.09M |
| March 31, 2024 | 913.49M |
| December 31, 2023 | 981.33M |
| September 30, 2023 | 778.94M |
| June 30, 2023 | 811.64M |
| March 31, 2023 | 761.51M |
| December 31, 2022 | 733.47M |
| September 30, 2022 | 714.48M |
| June 30, 2022 | 800.16M |
| March 31, 2022 | 829.07M |
| December 31, 2021 | 826.74M |
| Date | Value |
|---|---|
| September 30, 2021 | 853.81M |
| June 30, 2021 | 548.55M |
| March 31, 2021 | 422.43M |
| December 31, 2020 | 245.56M |
| September 30, 2020 | 200.07M |
| June 30, 2020 | 230.82M |
| March 31, 2020 | 261.39M |
| December 31, 2019 | 100.94M |
| September 30, 2019 | 126.72M |
| June 30, 2019 | 143.65M |
| December 31, 2018 | 134.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
100.94M
Minimum
Dec 2019
981.33M
Maximum
Dec 2023
632.99M
Average
770.22M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.807B |
| Perspective Therapeutics Inc | 328.47M |
| Electromed Inc | 41.49M |
| Xtant Medical Holdings Inc | 45.72M |
| Myomo Inc | 9.292M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.171B |
| Total Liabilities (Quarterly) | 380.05M |
| Current Ratio | 5.688 |